Myopia Treatments: How to Choose and When to Use?

Effective management in children and young adults may require different interventions. Learn which works best for your case.

A New Way to Detect Patients Who Don’t Take Their Meds

Exploratory assay that measures drug concentration provides comprehensive medication monitoring.

New Anti-VEGF Delivery Method Reduces Treatment Burden

Study: 80% of AMD patients required no additional therapy for six months.

Are Meds a Culprit for Uveitis?

Review points to link, especially with newer drugs.

Neurotrophic Keratitis Finally Gets a Therapy

The first drug to treat this condition demonstrated healing in 70% of patients.

New Topical Steroid Hits the Market

Inveltys offers BID dosing and a higher concentration.

White: Not Just for Brides

The FDA recently approved a new over-the-counter alpha-adrenergic receptor agonist designed to clear your patients’ red eyes.

Migraine Sufferers May Get Relief from Glaucoma Drops

Quick-acting timolol takes effect in 15 minutes.

Anticholinergic Drugs Increase AMD Risk

New data suggests a dose-dependent association for a wide swath of medications.

Large Study Confirms Topical Glaucoma Meds, CME Association

Mainstay drugs trigger inflammatory mediators that lead to edema.

Upcoming Events

February 15-19, 2019

Annual Winter Ophthalmic Conference
Location: The Westin Snowmass Conference Hotel
Program Chairs: Murray Fingeret, OD, and Leo Semes, OD
Up to 20 CE credits (COPE approval pending)
Register here


March 7-10, 2019

New Technologies & Treatments in Eye Care—Orlando, FL
Location: Disney’s Yacht & Beach Club
Program Chair: Paul Karpecki, OD, FAAO
Up to 20 CE credits (COPE approval pending)
Register here

April 11-13, 2019

New Technologies & Treatments in Eye Care—San Diego
Location: Manchester Grand Hyatt
Program Chair: Paul Karpecki, OD, FAAO
Up to 19 CE Credits (COPE approval pending)
Register here


Jobs Powered By Local Eye Site